ダウンロード数: 305
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
jrr_rrt098.pdf | 117.75 kB | Adobe PDF | 見る/開く |
タイトル: | Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. |
著者: | Suzuki, Minoru https://orcid.org/0000-0002-5421-9417 (unconfirmed) Kato, Ituro Aihara, Teruhito Hiratsuka, Junichi Yoshimura, Kenichi Niimi, Miyuki Kimura, Yoshihiro Ariyoshi, Yasunori Haginomori, Shin-Ichi Sakurai, Yoshinori https://orcid.org/0000-0001-9404-4255 (unconfirmed) Kinashi, Yuko Masunaga, Shin-Ichiro Fukushima, Masanori Ono, Koji Maruhashi, Akira |
著者名の別形: | 鈴木, 実 |
キーワード: | boron neutron capture therapy head and neck tumors |
発行日: | 1-Jan-2014 |
出版者: | Oxford University Press |
誌名: | Journal of radiation research |
巻: | 55 |
号: | 1 |
開始ページ: | 146 |
終了ページ: | 153 |
抄録: | We retrospectively review outcomes of applying boron neutron capture therapy (BNCT) to unresectable advanced or recurrent head and neck cancers. Patients who were treated with BNCT for either local recurrent or newly diagnosed unresectable head or neck cancers between December 2001 and September 2007 were included. Clinicopathological characteristics and clinical outcomes were retrieved from hospital records. Either a combination of borocaptate sodium and boronophenylalanine (BPA) or BPA alone were used as boron compounds. In all the treatment cases, the dose constraint was set to deliver a dose <10-12 Gy-eq to the skin or oral mucosa. There was a patient cohort of 62, with a median follow-up of 18.7 months (range, 0.7-40.8). A total of 87 BNCT procedures were performed. The overall response rate was 58% within 6 months after BNCT. The median survival time was 10.1 months from the time of BNCT. The 1- and 2-year overall survival (OS) rates were 43.1% and 24.2%, respectively. The major acute Grade 3 or 4 toxicities were hyperamylasemia (38.6%), fatigue (6.5%), mucositis/stomatitis (9.7%) and pain (9.7%), all of which were manageable. Three patients died of treatment-related toxicity. Three patients experienced carotid artery hemorrhage, two of whom had coexistent infection of the carotid artery. This study confirmed the feasibility of our dose-estimation method and that controlled trials are warranted. |
著作権等: | © The Author 2013. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
URI: | http://hdl.handle.net/2433/182047 |
DOI(出版社版): | 10.1093/jrr/rrt098 |
PubMed ID: | 23955053 |
出現コレクション: | 学術雑誌掲載論文等 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。